On Tuesday, President Donald Trump responded to Speaker of the House Nancy Pelosi’s jab where she called him “morbidly obese” while explaining why he should not be taking doctor prescribed hydroxychloroquine. The President suggested that Pelosi has “mental problems.”

“President Trump, last night Speaker of the House Nancy Pelosi called you morbidly obese. I just wanted to know what you had to say in response to that?” Reporter for the Daily Caller Henry Rodgers asked.

“Oh, I don’t respond to her, I think she’s a waste of time,” the president replied.

“These people are sick. Pelosi is a sick woman,” President Trump added.

“She’s got a lot of problems. A lot of mental problems. We’re dealing with people that have to get their act together for the good of the country,” he continued.

During an interview on Monday, Pelosi mocked President Trump by calling him “morbidly obese.”

“As far as the president is concerned, he’s our president and I would rather he not be taking something that has not been approved by the scientists, especially in his age group and in his, shall we say, weight group, morbidly obese, they say,” Pelosi said. “So I think it’s not a good idea.”

The comment from the speaker made zero sense considering she is not a doctor nor a scientist. The President’s professional doctor recommended hydroxychloroquine because the “potential benefit from treatment outweighed the relative risks.”

The Daily Wire reports:

Pelosi’s assertion that Trump should not take hydroxychloroquine due to him being overweight and due to his age also does not make sense because she confused those risk factors with the factors that put people at the greatest of serious illness or death if they become infected with the coronavirus, not if they take the medication.

CNN’s Anderson Cooper did not push back on Pelosi’s remarks.

WATCH the clip below:

On Monday, White House doctor Sean Conley released a letter detailing President Trump’s health and what they were doing to safeguard against the coronavirus: “After numerous discussions he and I had regarding the evidence for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks. In conclusion with our inter-agency partners and subject matter experts around the country, I continue to monitor the myriad studies investigating potential COVID-19 therapies, and I anticipate employing the same shared medical decision making based on the evidence at hand in the future.”